Events
GRASP brings patients and researchers together for small-group conversations that make cancer science more accessible, collaborative, and deeply informed by patient experience.
Poster Walkthroughs are virtual small group sessions where advocates and researchers discuss posters from cancer conferences.
ESMO: Group 2D: Breast Cancer & Central Nervous System Metastases
Tuesday, November 3, 2026
4:00–5:30 PM CET/Madrid
10:00–11:30 AM ET/New York
The ESMO Congress 2026 is a leading global oncology event showcasing the latest advances in cancer research and treatment. GRASP provides a unique opportunity for advocates and clinical researchers to join the conversation through Poster Walkthroughs.
Register Below
This ESMO26 Poster Walkthrough group will explore key findings from the following posters:
Poster #4663P: Comparing Risk of CNS Metastasis Between HER2-Low and HER2-Zero Metastatic Triple Negative Breast Cancer
Poster #1796TiP: BREnnA: Phase II/III randomised study of ZN-A-1041 or tucatinib (TUC), in combination with trastuzumab + capecitabine (HX), in patients (pts) with HER2-positive locally advanced or metastatic breast cancer (HER2+ LA/mBC) with or without central nervous system (CNS) metastases
Keywords: HER2+ Breast Cancer; HER2-low Breast Cancer; Triple Negative Breast Cancer; Brain metastasis; Leptomeningeal Disease (LMD)
Patient Advocate
Advocate Mentor
Scientist
Shadow Mentor
Shadow Scientist
